Variant report
Variant | nsv974028 |
---|---|
Chromosome Location | chr13:69505627-69533104 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1340720 | chr13:69512812-69512813 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs74740542 | chr13:69512825-69512826 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs572524635 | chr13:69512844-69512845 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs185907886 | chr13:69512845-69512846 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs551750164 | chr13:69512860-69512861 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs149737978 | chr13:69512861-69512862 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs571579528 | chr13:69512865-69512866 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs9529460 | chr13:69512921-69512922 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs371586715 | chr13:69512933-69512934 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs190317364 | chr13:69512940-69512941 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs565857020 | chr13:69512942-69512943 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs547181658 | chr13:69512945-69512946 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs376832089 | chr13:69512951-69512952 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs573867262 | chr13:69512958-69512959 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs147671368 | chr13:69512982-69512983 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs552608089 | chr13:69512983-69512984 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs572882144 | chr13:69513008-69513009 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs544820546 | chr13:69513035-69513036 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs564884733 | chr13:69513037-69513038 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs575150296 | chr13:69513047-69513048 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs61950962 | chr13:69513051-69513052 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs561171173 | chr13:69513055-69513056 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs529875726 | chr13:69513065-69513066 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs369334229 | chr13:69513075-69513076 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs546809244 | chr13:69513085-69513086 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs560135383 | chr13:69513098-69513099 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs528564235 | chr13:69513130-69513131 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs551617200 | chr13:69513133-69513134 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs140672699 | chr13:69513169-69513170 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs144723709 | chr13:69513181-69513182 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs61950963 | chr13:69513194-69513195 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs567627257 | chr13:69513212-69513213 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs536585396 | chr13:69513239-69513240 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs543788128 | chr13:69513242-69513243 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs73209773 | chr13:69513253-69513254 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs7999508 | chr13:69513258-69513259 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs147916279 | chr13:69513316-69513317 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs558393434 | chr13:69513327-69513328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs61950964 | chr13:69513343-69513344 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs6562545 | chr13:69513349-69513350 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs35849658 | chr13:69513356-69513357 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs377456072 | chr13:69513394-69513395 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs560907721 | chr13:69513411-69513412 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs574782230 | chr13:69513473-69513474 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs540562215 | chr13:69513534-69513535 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs79690767 | chr13:69513562-69513563 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs527425458 | chr13:69513576-69513577 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs532222352 | chr13:69513600-69513601 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs545455069 | chr13:69513620-69513621 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs9572045 | chr13:69513690-69513691 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Prostate cancer | 16461572 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Breast cancer | 22737080 | CNVD |
T-cell lymphomas | 22341440 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:69512800-69515200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
2 | chr13:69513200-69514400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
3 | chr13:69513200-69514600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
4 | chr13:69513200-69515000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
5 | chr13:69513600-69514600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr13:69513800-69514600 | Enhancers | H9 Cell Line | embryonic stem cell |
7 | chr13:69514000-69514600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
8 | chr13:69514000-69514600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
9 | chr13:69514400-69514800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
10 | chr13:69516400-69516600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |